Literature DB >> 227875

Effect of antimitotic drugs on tubulin GTPase activity and self-assembly.

T David-Pfeuty, C Simon, D Pantaloni.   

Abstract

Microtubule inhibitors can be classified into two categories: 1) those which inhibit the polymerization-dependent GTPase activity of phosphocellulose-purified tubulin, but induce a significant polymerization-independent GTPase activity (e.g. colchicine, griseofulvine, daunorubicine); 2) those which inhibit the GTPase activity associated with tubulin polymerization and that induced by inhibitors of the first class (e.g. the vincaalkaloids and podophyllotoxin). The colchicine-stimulated GTPase activity of tubulin appears to be due to the tubulin.colchicine complex. This suggests that colchicine inhibits tubulin assembly by binding to a tubulin-tubulin interaction site required for the polymerization-dependent GTPase activity and induces by itself a tubulin conformational change that leads to polymerization-independent GTPase activity. Stoichiometry of inhibition by vinblastine of the colchicine-stimulated GTPase activity is 1:2. On the other hand, the inhibition by vinblastine of the tubulin self-assembly and of the polymerization-dependent GTPase activity is strongly substoichiometric at the beginning of the polymerization reaction, 1 vinblastine molecule inhibiting the ability of 10 tubulin dimers to polymerize and to hydrolyze the GTP. However, at the polymerization plateau, the inhibition effect by vinblastine appears to be lower, suggesting a selective action of vinblastine on the early stages of the polymerization reaction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Antimicrotubular drugs binding to vinca domain of tubulin.

Authors:  Suvroma Gupta; Bhabatarak Bhattacharyya
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

2.  A molecular and structural mechanism for G protein-mediated microtubule destabilization.

Authors:  Rahul H Davé; Witchuda Saengsawang; Manu Lopus; Sonya Davé; Leslie Wilson; Mark M Rasenick
Journal:  J Biol Chem       Date:  2010-11-26       Impact factor: 5.157

Review 3.  Heterotrimeric G-proteins interact directly with cytoskeletal components to modify microtubule-dependent cellular processes.

Authors:  Rahul H Dave; Witchuda Saengsawang; Jiang-Zhou Yu; Robert Donati; Mark M Rasenick
Journal:  Neurosignals       Date:  2009-02-12

4.  Kinetic analysis of tubulin assembly in the presence of the microtubule-associated protein TOGp.

Authors:  Claude Bonfils; Nicole Bec; Benjamin Lacroix; Marie-Cécile Harricane; Christian Larroque
Journal:  J Biol Chem       Date:  2006-12-17       Impact factor: 5.157

5.  Structural insight into the inhibition of tubulin by vinca domain peptide ligands.

Authors:  Anthony Cormier; Matthieu Marchand; Raimond B G Ravelli; Marcel Knossow; Benoît Gigant
Journal:  EMBO Rep       Date:  2008-09-12       Impact factor: 8.807

Review 6.  Mechanical modulation of cardiac microtubules.

Authors:  Ed White
Journal:  Pflugers Arch       Date:  2011-04-13       Impact factor: 3.657

7.  Phosphatidylinositol 4,5-bisphosphate modifies tubulin participation in phospholipase Cbeta1 signaling.

Authors:  Juliana S Popova; Arin K Greene; Jia Wang; Mark M Rasenick
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

8.  Localization of the colchicine-binding site of tubulin.

Authors:  S Uppuluri; L Knipling; D L Sackett; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  Tubulin bound to colchicine forms polymers different from microtubules.

Authors:  J M Andreu; S N Timasheff
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

10.  Inhibitors of tubulin assembly identified through screening a compound library.

Authors:  Rachel E Morgan; Sunnoo Ahn; Sandra Nzimiro; Jean Fotie; Mitch A Phelps; Jeffrey Cotrill; Adam J Yakovich; Dan L Sackett; James T Dalton; Karl A Werbovetz
Journal:  Chem Biol Drug Des       Date:  2008-12       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.